Stock Research for CCXI

Current Price


Latest Update: 2018-02-16 16:00:00

$ 9.4700
$ 9.4500
$ 9.4700

Featured Broker: TradeStation

Get the due diligence for another stock.


CCXI Stock Chart & Research Data

The CCXI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CCXI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CCXI Due diligence Resources & Stock Charts

The CCXI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CCXI Detailed Price Forecast - CNN Money CNN View CCXI Detailed Summary - Google Finance
Yahoo View CCXI Detailed Summary - Yahoo! Finance Zacks View CCXI Stock Research & Analysis -

Stock Analysis

TradeIdeas View CCXI Trends & Analysis - Trade-Ideas Barrons View CCXI Major Holders - Barrons
NASDAQ View CCXI Call Transcripts - NASDAQ Seeking View CCXI Breaking News & Analysis - Seeking Alpha
Spotlight View CCXI Annual Report - OTC Report View CCXI OTC Short Report -
TradeKing View CCXI Fundamentals - TradeKing Charts View CCXI SEC Filings - Bar Chart
WSJ View Historical Prices for CCXI - The WSJ Morningstar View Performance/Total Return for CCXI - Morningstar
MarketWatch View the Analyst Estimates for CCXI - MarketWatch CNBC View the Earnings History for CCXI - CNBC
StockMarketWatch View the CCXI Earnings - StockMarketWatch MacroAxis View CCXI Buy or Sell Recommendations - MacroAxis
Bullish View the CCXI Bullish Patterns - American Bulls Short Pains View CCXI Short Pain Metrics -

Social Media Mentions

StockTwits View CCXI Stock Mentions - StockTwits PennyStocks View CCXI Stock Mentions - PennyStockTweets
Twitter View CCXI Stock Mentions - Twitter Invest Hub View CCXI Investment Forum News - Investor Hub
Yahoo View CCXI Stock Mentions - Yahoo! Message Board Seeking Alpha View CCXI Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CCXI - Insider Cow View Insider Transactions for CCXI - Insider Cow
CNBC View CCXI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CCXI - OTC Markets
Yahoo View Insider Transactions for CCXI - Yahoo! Finance NASDAQ View Institutional Holdings for CCXI - NASDAQ

Stock Charts

FinViz View CCXI Stock Insight & Charts - StockCharts View CCXI Investment Charts -
BarChart View CCXI Stock Overview & Charts - BarChart Trading View View CCXI User Generated Charts - Trading View

Latest Financial News for CCXI

ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor CCX872 for Locally Advanced/Metastatic Pancreatic Cancer
Posted on Monday January 22, 2018

--CCX872 plus FOLFIRINOX resulted in overall survival of 29 percent at 18 months in all patients--. --Clinical findings to be presented at 2018 ASCO-SITC Clinical Immuno-Oncology Symposium--. MOUNTAIN ...

ChemoCentryx Strengthens Senior Executive Team with the Appointment of William Fairey as Executive Vice President and Chief Operating Officer
Posted on Monday January 08, 2018

MOUNTAIN VIEW, Calif., Jan. 08, 2018-- ChemoCentryx, Inc.,, a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today announced the appointment ...

3 Biotech Stocks That Soared This Week: Are They Buys?
Posted on Saturday January 06, 2018

Sorrento Therapeutics, ChemoCentryx, and Insys started off 2018 great. But can their momentum continue?

Here's Why ChemoCentryx Rose as Much as 53.5% Today
Posted on Thursday January 04, 2018

The tiny biopharma stock is cruising on today's news. Does it deserve the pop?

Comparing ChemoCentryx (CCXI) and Kamada (KMDA)
The Lincolnian Online - Nov 10, 2017
ChemoCentryx logo ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer.

ChemoCentryx Announces Positive Overall Survival Results with CCR2 Inhibitor ...
GlobeNewswire (press release) - Jan 22, 2018
MOUNTAIN VIEW, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), announced today positive overall survival (OS) results from an ongoing Phase Ib clinical trial of the Company's second CCR2 inhibitor - CCX872 - in the ...

ChemoCentryx Inc. (CCXI) Soars 5.25% on February 14 - Feb 14, 2018
ChemoCentryx Inc. (CCXI) had a good day on the market for Wednesday February 14 as shares jumped 5.25% to close at $9.63. About 373,950 shares traded hands on 1,818 trades for the day, compared with an average daily volume of 143,773 shares out of a ...
Here's how analysts see ChemoCentryx, Inc. (NASDAQ:CCXI) after this past week. - BZ Weekly
It's been a crucial week for ChemoCentryx, Inc. (NASDAQ:CCXI); here's what ... - Reurope

ChemoCentryx, Inc. (CCXI) EPS Estimated At $-0.22
BZ Weekly - Feb 18, 2018
Bvf Il owns 7.59 million shares for 7.16% of their portfolio. The Texas-based Smith Asset Mgmt Grp Inc Ltd Partnership has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). Geode Capital Management Ltd Company holds 0% or 241,907 shares in its ...
EPS for ChemoCentryx, Inc. (CCXI) Expected At $-0.22 - Frisco Fastball
$-0.22 EPS Expected for ChemoCentryx, Inc. (CCXI) - Reurope

Enter a stock symbol to view the stock details.